IRIS
LAZZARINO, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.961
AS - Asia 5.716
EU - Europa 4.549
SA - Sud America 608
Continente sconosciuto - Info sul continente non disponibili 158
AF - Africa 132
OC - Oceania 8
Totale 20.132
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.617
CN - Cina 3.069
SG - Singapore 1.160
IE - Irlanda 819
UA - Ucraina 812
HK - Hong Kong 632
DE - Germania 534
FI - Finlandia 521
BR - Brasile 436
IT - Italia 429
RU - Federazione Russa 375
VN - Vietnam 343
SE - Svezia 322
FR - Francia 298
GB - Regno Unito 253
CA - Canada 149
IN - India 106
BD - Bangladesh 68
AR - Argentina 58
ZA - Sudafrica 46
IQ - Iraq 44
MX - Messico 44
NL - Olanda 44
JP - Giappone 37
TR - Turchia 32
CR - Costa Rica 29
VE - Venezuela 28
PK - Pakistan 27
ID - Indonesia 26
IL - Israele 25
PL - Polonia 25
BE - Belgio 24
ES - Italia 24
CW - ???statistics.table.value.countryCode.CW??? 23
PH - Filippine 21
CO - Colombia 20
EC - Ecuador 20
NI - Nicaragua 18
PY - Paraguay 18
SA - Arabia Saudita 17
SV - El Salvador 17
GT - Guatemala 16
JO - Giordania 16
TT - Trinidad e Tobago 15
HN - Honduras 13
LT - Lituania 13
SC - Seychelles 13
TN - Tunisia 13
JM - Giamaica 12
KE - Kenya 11
UZ - Uzbekistan 11
CL - Cile 10
MA - Marocco 10
MY - Malesia 10
GP - Guadalupe 9
AZ - Azerbaigian 8
IR - Iran 8
PE - Perù 8
PR - Porto Rico 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
MU - Mauritius 7
PA - Panama 7
AT - Austria 6
BO - Bolivia 6
DZ - Algeria 6
CZ - Repubblica Ceca 5
EG - Egitto 5
EU - Europa 5
GR - Grecia 5
KZ - Kazakistan 5
OM - Oman 5
RO - Romania 5
TH - Thailandia 5
AL - Albania 4
AO - Angola 4
LV - Lettonia 4
NG - Nigeria 4
PT - Portogallo 4
SN - Senegal 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
BY - Bielorussia 3
EE - Estonia 3
ET - Etiopia 3
KG - Kirghizistan 3
KR - Corea 3
LB - Libano 3
MN - Mongolia 3
NP - Nepal 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
CH - Svizzera 2
DK - Danimarca 2
GE - Georgia 2
HR - Croazia 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
Totale 19.975
Salva come PNG Salva come JPEG
Città #
Jacksonville 960
Chandler 923
San Jose 824
Dublin 819
Nanjing 765
Hong Kong 622
Ashburn 591
Singapore 569
Council Bluffs 486
Dallas 410
Beijing 348
Boardman 346
Nanchang 294
New York 260
Hebei 213
Princeton 207
Shenyang 204
Lawrence 203
Medford 196
Changsha 187
Los Angeles 173
Lauterbourg 170
Wilmington 170
Jiaxing 155
Ann Arbor 141
Tianjin 120
Hangzhou 119
Ho Chi Minh City 115
Buffalo 92
Milan 90
Helsinki 88
Hanoi 87
Santa Clara 81
Redondo Beach 58
Moscow 56
Woodbridge 52
Shanghai 51
Verona 50
Falkenstein 45
São Paulo 38
Munich 37
Toronto 37
Montreal 36
Norwalk 35
Orem 35
Brooklyn 33
Tokyo 33
Rome 31
Johannesburg 29
Seattle 29
Turku 29
Houston 27
Des Moines 25
Frankfurt am Main 25
Brussels 24
Atlanta 23
Jinan 23
Willemstad 23
San Francisco 20
Baghdad 19
Chicago 19
Warsaw 19
Managua 18
Zhengzhou 18
Auburn Hills 17
Da Nang 17
Fairfield 17
Kunming 17
San José 17
Ningbo 16
Stockholm 16
Amsterdam 15
Amman 14
Guangzhou 14
London 14
San Salvador 14
Charlotte 13
Columbus 13
Haiphong 13
Naples 13
Phoenix 13
The Dalles 13
Ankara 12
Chennai 12
Denver 12
Mexico City 12
Pavia 12
Philadelphia 12
Pune 12
Rio de Janeiro 12
The Bronx 12
Belo Horizonte 11
Dhaka 11
Guatemala City 11
Lanzhou 11
Nuremberg 11
Tashkent 11
Boston 10
Manchester 10
Nairobi 10
Totale 12.495
Salva come PNG Salva come JPEG
Nome #
A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis 203
A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications. 199
Pharmacokinetic behavior of Rituximab: a study of different schedules of administration for heterogeneous clinical settings. 177
Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT. 172
A low serum beta 2-microglobulin level despite bulky tumor is a characteristic feature of primary mediastinal (thymic) large B-cell lymphoma: implicatios for serologic staging. 167
A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment) 164
Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndrome 161
Blast phase of essential thrombocythemia: A single center study. 160
Blood p50 evaluation enhances diagnostic definition of isolated erythrocytosis. 160
Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometry. 158
CD30/Ki-1-positive lymphoproliferative disorders of the skin--clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group. 153
A WHO classification-based prognostic scoring system (WPSS) for predicting survival in myelodysplastic syndromes 153
Analisi in citometria a flusso dei pattern differenziativi della leucemia mieloide cronica in crisi blastica. Uno studio immunofenotipico di 26 casi consecutivi 146
EFFICACY OF PIPOBROMAN IN THE TREATMENT OF POLYCYTHEMIA VERA: LONG TERM RESULTS IN 163 PATIENTS 142
Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations 142
Clinical significance of neutrophil CD177 mRNA expression in Ph-negative chronic myeloproliferative disorders 141
Alterazioni Citogenetiche nelle sindromi mielodisplastiche 141
Adult ki-1-positive large cell anaplastic lymphoma presenting with skin lesions. 139
ALK+ lymphoma: clinico-pathological findings and outcome. 136
Splenic nodal and extranodal marginal zone lymphoma: features of bone marrow involvement. 136
Multiple granulocytic sarcoma during complete hematologic remission of acute nonlymphoid leukemia. 135
Epstein-Barr Virus positive aggressive lymphoma as a consequence of immunosuppression after multiple salvage treatments for follicular lymphoma. 134
A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma. 133
Etoposide : il citostatico della linea monocitica 132
Splenic marginal zone lymphoma: clinical clustering of immunoglobulin heavy chain repertoires 131
A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial 129
Anemia refrattaria con eccesso di blasti : caratteristiche clinico-ematologiche ed implicazioni terapeutiche 127
A young woman with microcytic anemia and hypertransaminasemia 127
Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis 126
Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. 126
Allogeneic versus autologous BMT versus intensive post-remission chemotherapy in acute leukemias 124
Alterazioni dell’emostasi nelle leucemie e nei tumori solidi 123
Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipation 122
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes 121
The efficacy of cognitive stimulation, cognitive training, and cognitive rehabilitation for people living with dementia: a systematic review and meta-analysis 120
JAK2 (V617F) mutation in healthy individuals 119
Immune-mediated neuropathies in myeloma patients treated with bortezomib. 119
Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia 119
Citosina arabinoside a basse dosi con o senza 1,25diidrossi vitamina D3 nella terapia delle sindromi mielodisplastiche e nele leucemie acute dell’anziano 119
Chemioterapia della leucemia acuta linfoblastica dell’adulto: l’induzione della remissione e la profilassi meningea 118
ABL1 amplification in T-cell acute lymphoblastic leukemia. 118
EFFICACY OF A IDARUBICIN, ETOPOSIDE AND INTERMEDIATE-DOSE CYTARABINE ARABINOSIDE AS SALVAGE THERAPY IN RELAPSING OR RESISTANT UNFAVORABLE LYMPHOMA 117
Management of nodal diffuse large B-cell lymphomas: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation. 115
Bone marrow CD34+ cell count is predictive for adequate peripheral progenitor cell collection 115
Consolidation treatment with autologous peripheral blood progenitor cell transplantation in acute myeloid leukemia 114
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics. 114
Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia. 114
Outcome of four patients with chronic myeloid leucemia after imatinib mesylate discontinuation. 113
Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders. 113
Predictive variables for malignant transformation in 452 patients with asymptomatic IgM monoclonal gammopathy 112
Ara-c ad alte dosi (HD-Ara-c) per il trattamento della malattia meningea nella leucemia acuta linfoblastica (LAL) e nei Linfomi non Hodgkin (LNH): studio di 25 casi 112
Mediastinal B-cell lymphoma: a study of its histomorphologic spectrum based on 109 cases 110
PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia 110
Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomas. 109
Nodular lymphocyte predominance Hodgkin's disease: long-term observation reveals a continuous pattern of recurrence. 109
Central nervous system relapse in acute promyelocytic leucemia 108
Evolving approaches with alpha interferon in chronic myelogenous leukemia 108
Lymph node reticulum cell neoplasm with progression into cytokeration-positive interstitial reticulum cell (CIRC) sarcoma: a case study 107
Impact of advanced age on the management of acute nonlymphocytic leukemia: a study of 103 patients 107
Management of nodal diffuse large B-cell lymphomas : practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation 106
Limited feasibility of double transplant in multiple myeloma: results of a multicenter study on 153 patients aged <65 years. 105
Thiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant. 105
Clinical characteristics and outcome of immunoglobulin M-related disorders 104
Valutazione prognostica dele sindromi mielodisplastiche 104
Treatment of relapsed and refractory acute myloid leukemia in adults 104
Primary mediastinal B-cell lymphoma: update of its clinicopathologic features. 104
Increase in leukocyte count over time predicts thrombosis in patients with low-risk essential thrombocythemia. 104
Osteoprotegerin serum levels in multiple myeloma and MGUS patients compared with age- and sex-matched healthy controls 103
Late onset of bortezomib-associated cutaneous reaction following herpes zoster 103
Molecular remission after allo-SCT in a patient with post-essential thrombocythemia myelofibrosis carrying the MPL (W515A) mutation. 102
Dose-dense R-CHOP-14 supported by pegfilgrastim in patients with diffuse large B-cell lymphoma: a phase II study of feasibility and toxicity. 101
Rapid response to high-dose steroids of severe bortezomib-related pulmonary complication in multiple myeloma. 101
Exaggerated insect bite-like reaction in patients affected by oncohaematological diseases 101
Le sindromi mielodisplastiche : molteplicita’ degli aspetti ematologici e clinici 101
Strategie per la mobilizzazione di progenitori emopoietici nel sangue periferico 101
Validation of follicular lymphoma international prognostic index 2 (FLIPI2) score in an independent series of follicular lymphoma patients 101
Incidenza della monosomia 7 in corso di crisi blastica della leucemia mieloide cronica (LMC) Ph1 positiva 101
TREATMENT OF EARLY STAGE HODGKIN’S DISEASE WITH FOUR CYCLES OF ABVD FOLLOWED BY ADJUVANT RADIOTHERAPY: ANALYSIS OF EFFICACY AND LONG TERM TOXICITY 100
Urinary proteins in multiple myeloma. correlation with clinical parameters and diagnostic implications 99
Incidence of leukaemia in patients with primary myelofibrosis and RBC-transfusion-dependence. 99
Criopreservation of marrow cells for ABMT : is there any effect on the harvested leukemic cell? 99
Long-term follow-up of young patients with essential thrombocythemia treated with pipobroman. 98
Impiego clinico di agenti antineoplastici ad alte dosi in oncoematologia: methotrexate e citosina arabinoside 98
Treatment of Ph1 positive chronic myelogenous leukemia (CML) with recombinant interferon alpha 2b (Intron A) 98
Carateristiche cliniche peculiari delle leucemie acute monocitiche e loro rilievo prognostico 98
Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease 96
Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow-up 96
Interferon alpha-2b as therapy for patients with Ph1 positive chronic myelogenous leukemia 95
Primary gastric CD30 (Ki-1)positive large cell Non Hodgkin Lymphomas. A clinicopathologic analysis six cases. 95
Long-term outcome of ph-negative acute lymphoblastic leukaemia in adults: a single centre experience. 94
Complicanze emorragiche e trombotiche nel paziente chirurgico 94
Pathogenetic significance of “pure” monosomy 7 in myeloproliferative disorders. Analyses of 14 cases 94
Severe intestinal vasculitis in a patient under treatment with bortezomib. 93
Zoledronic acid exerts its antitumor effect in multiple myeloma interfering with the bone marrow microenvironment 93
A striking response to bortezomib in a patient with pleural localization of multiple myeloma 93
Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients. 92
Mielodiplasia secondarie a prgressa terapia antineoplastica 92
Combined etoposide (VP 16) and cytarabine (ARA-C) for acute myelogenous leukemia (AML) evolving from myelodysplastic syndromes (MDS) or secondary to treatment for malignant disease 92
Interferon alpha2b in the treatment of Ph1 negative myeloproliferative disoders with excessive thrombocytosis 92
Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients 92
Totale 11.822
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.286
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.286
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022835 0 0 0 0 25 43 10 49 46 26 136 500
2022/20232.621 295 169 28 222 328 292 1 168 995 20 78 25
2023/20241.018 98 166 28 88 75 398 11 71 10 18 31 24
2024/20252.367 43 236 70 78 63 55 78 236 515 51 223 719
2025/20265.388 392 426 581 554 540 291 1.084 195 462 503 225 135
2026/20272.001 141 349 393 767 351 0 0 0 0 0 0 0
Totale 20.132